inflammatory markers

Researchers say they have identified several signs of inflammation in patients with malignant mesothelioma that might be used to predict how patients will respond to treatment. Doctors from the Department of Chest Diseases at Dicle University collected data on 155 patients at the time of their mesothelioma diagnosis and compared it to their survival. The information collected included the extent of each patient’s exposure to asbestos, the histological subtype of their mesothelioma, and other laboratory measures. The mean survival time for all mesothelioma patients in the study was 13.9 months. When the researchers considered one potential prognostic factor at a time, they found that being 60 years old or over and having a neutrophil-to-lymphocyte ratio (NLR) of 3 or more…